Your browser is no longer supported. Please, upgrade your browser.
Settings
VUG Vanguard Growth Index Fund daily Stock Chart
VUG [NYSE]
Vanguard Growth Index Fund
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.47%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.15%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-5.03%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.58 Perf Half Y5.82%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year17.14%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range121.66 - 152.38 Perf YTD1.56%
Dividend1.60 P/FCF- EPS past 5Y- ROI- 52W High-6.25% Beta-
Dividend %1.12% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low17.42% ATR2.37
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)48.57 Volatility1.15% 1.79%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.89 Prev Close143.12
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.10M Price142.85
Recom- SMA200.58% SMA50-1.16% SMA2003.15% Volume980,292 Change-0.19%
Apr-05-18 04:00PM  5 Ultra-Cheap Growth ETFs for a Large-Cap Play This Spring InvestorPlace
Feb-15-18 02:33PM  7 of the Best Growth ETFs InvestorPlace
Feb-01-18 12:40PM  What Yellen's Final Meeting Means for These ETFs Zacks
Jan-29-18 07:48AM  Another Record for Smart Beta Assets Investopedia
Jan-25-18 11:37AM  Analyst Ratings for Thermo Fisher Scientific before 4Q17 Results Market Realist
Jan-16-18 04:52PM  3 Large-Cap Growth ETFs for Your Portfolio Zacks
Jan-10-18 07:38AM  AbbVies Rova-T: Solid Growth Driver for the Future? Market Realist
07:38AM  Whats Driving Baxter Internationals Cash Flow Growth Market Realist
07:31AM  AbbVies Position in the Growing Oncology Market in 2018 Market Realist
Jan-04-18 02:16PM  7 Best Cheap Index Funds and ETFs to Buy InvestorPlace
Jan-03-18 07:33AM  Align Technologys Customer Acquisition Strategy Driving Market Growth Market Realist
Nov-30-17 09:50AM  Can Smart Beta Go Wrong? Market Realist
Nov-15-17 07:17PM  3 Top Vanguard ETFs in 2017 Motley Fool
Nov-01-17 08:00AM  Getting Better Acquainted With Smart Beta ETFs Investopedia
Oct-20-17 04:36PM  Allergan Stock: Performance in 3Q17 Market Realist
Oct-19-17 10:27AM  Vanguard, genocide, and the $18 million campaign to get you to vote Yahoo Finance Video
Oct-18-17 02:19PM  Vanguard, genocide, and the $18 million campaign to get you to vote Yahoo Finance
Oct-13-17 03:45PM  3 Top Ranked Large-Cap Growth ETFs for Your Portfolio Zacks
Sep-28-17 08:15AM  A Solid Start For This New ETF Benzinga
Sep-19-17 08:07AM  Could Mylans Biosimilar Portfolio Be a Long-Term Growth Driver? Market Realist
Sep-15-17 12:35PM  BD Stock Fell 2.7% on September 13: Should Investors Worry? Market Realist
10:57AM  Going With Growth ETFs Benzinga
Sep-14-17 04:22PM  10 Super-Cheap Vanguard ETFs for Investors ETF Trends
Sep-13-17 03:50PM  ETF Price War Is Heating Up; That's Bad News for Some Fund Firms Barrons.com
Sep-04-17 10:37AM  Boston Scientifics Updated 2017 Guidance Market Realist
Sep-01-17 09:07AM  How Are Orkambi and Kalydeco Positioned after 2Q17? Market Realist
Aug-31-17 01:02PM  Forget Geopolitics, Large-Cap Growth ETFs Still Strong Buys Zacks
09:08AM  Did Junes IT Disruption Hurt Medtronics Sales in Fiscal 1Q18? Market Realist
Aug-30-17 07:37AM  Dupixent and Kevzara: Regenerons Long-Term Growth Drivers? Market Realist
Aug-28-17 10:07AM  Headwind for Becton Dickinson: US Dispensing Business Market Realist
Aug-24-17 12:18AM  Growth May Keep Trouncing Value The Wall Street Journal
12:03AM  Growth May Keep Trouncing Value The Wall Street Journal
Aug-18-17 12:35PM  Will Medtronic Meet Analysts Earnings Estimates in Fiscal 1Q18? Market Realist
Aug-16-17 07:36AM  How Varian Is Harnessing Proton Therapy Market Opportunities Market Realist
Aug-10-17 09:07AM  Celgenes Otezla Witnessed High Revenue Growth in 2Q17 Market Realist
Aug-09-17 05:42PM  Michael Kors Beats 1Q18 Expectations, Raises Guidance Market Realist
Aug-04-17 05:30PM  1Q18: Will Michael Kors Post another Weak Quarter? Market Realist
Aug-03-17 10:36AM  Edwards Lifesciences Focuses on Indication Expansion of SAPIEN 3 in 2017 Market Realist
Aug-01-17 07:00AM  Large-Cap Growth and High-Yield Muni: 2 ETFs to Watch on Outsized Volume Zacks
Jul-27-17 03:14PM  ETF Winners & Losers on IMF Growth Forecast Zacks
Jul-19-17 02:25PM  Don't Miss 2 Top Growth Plays As Apple Goes For 9th Straight Win Investor's Business Daily
Jul-18-17 08:00AM  2 Tech-Heavy Funds Beating The Market Are Near Buy Point Investor's Business Daily
Jul-13-17 07:38AM  TMOs Oncomine Target Test Launch Will Boost This Business Market Realist
Jul-10-17 07:37AM  Why Orencia Could Be Just What BMY Needs in 2017 Market Realist
Jun-29-17 10:37AM  Biogens Interferon Therapies Could Witness Modest Fall in 2017 Market Realist
Jun-28-17 10:27AM  Get A Bunch Of ETFs With This New ETF Benzinga
Jun-26-17 12:22PM  A Momentum ETF Tries To Keep Its Edge Benzinga
06:00AM  How to Start Saving For Retirement Investopedia
Jun-23-17 07:36AM  Inside Vertex Pharmaceuticals Clinical Pipeline Market Realist
Jun-22-17 09:06AM  Otezla Could Significantly Drive Celgenes Revenue Growth Market Realist
Jun-20-17 09:07AM  Dupixent May Be a Major Growth Driver for Regeneron in 2017 Market Realist
Jun-19-17 07:37AM  How Stryker Plans to Capture the International Markets Market Realist
Jun-13-17 10:45AM  Humira May Continue to Drive AbbVies Revenue Growth Market Realist
09:06AM  New Kid in Town: Introducing TETF Market Realist
Jun-01-17 07:37AM  Analysts Views on Alexion Pharmaceuticals and Its Peers Market Realist
07:37AM  How Do Starbuckss Valuation Multiples Compare to Peers? Market Realist
May-30-17 07:36AM  Comparing Dividend Yields for SLB, HAL, and NOV Market Realist
May-25-17 10:40AM  5 Top-Ranked Growth ETFs & Stocks to Buy Now Zacks
07:36AM  Kyprolis Could Significantly Drive Amgens Revenue Growth in 2017 Market Realist
May-18-17 10:36AM  Inside Zoetiss Growth Strategy in 2017 Market Realist
May-17-17 12:22PM  Shining The Transparency Light On ETFs ETF.com
11:34AM  7 Large-Cap Growth ETFs That Are Sizzling Zacks
May-11-17 09:07AM  ALXN1210 Is Expected to Boost Alexion Pharmaceuticals Revenue Market Realist
May-04-17 02:35PM  Comparing the Dividend Yields of SLB, HAL, BHI, and NOV Market Realist
May-02-17 09:08AM  AbbVie Is Focused on Label Expansion of Imbruvica in 2017 Market Realist
May-01-17 09:09AM  What Are Strykers Key Growth Drivers for 2Q17? Market Realist
Apr-28-17 03:05PM  Chipotle Outperforms Analysts Growth Estimates in 1Q17 Market Realist
02:03PM  Dont Choose An ETF Based On Fees Alone ETF.com
10:34AM  Value Investing In ETFs Requires Time ETF.com
07:39AM  How Is McDonalds Expanding Its Business Now? Market Realist
Apr-26-17 10:28AM  3 ETFs to Trade the Breakout in Value Stocks Investopedia
Mar-16-17 04:39PM  Top 3 Large-Cap ETFs for 2017 Investopedia
04:39PM  Top 3 Large-Cap ETFs for 2017 at Investopedia
Feb-21-17 07:36AM  How Amgens Kyprolis Is Positioned in Second-Line Multiple Myeloma Segment Market Realist
07:36AM  How Amgens Kyprolis Is Positioned in Second-Line Multiple Myeloma Segment
Feb-16-17 10:36AM  Comparing the Dividend Yields of SLB, HAL, BHI, and NOV Market Realist
10:36AM  Comparing the Dividend Yields of SLB, HAL, BHI, and NOV
Feb-09-17 11:15AM  Large-Cap Growth ETFs Leading the Market Zacks
Feb-08-17 07:38AM  What Drove Chipotles Same-Store Sales Growth in 4Q16? Market Realist
07:38AM  What Drove Chipotles Same-Store Sales Growth in 4Q16?
Feb-01-17 12:57PM  January 2017 ETF Asset Scorecard Zacks
Jan-31-17 10:35AM  Gilead Sciences Plans to Diversify into the Oncology Sector Market Realist
10:35AM  Gilead Sciences Plans to Diversify into the Oncology Sector
Jan-26-17 09:57AM  A.M. Funds Roundup: What Follows Dow 20,000? Investors Leave Vanguard Growth ETF Barrons.com
09:57AM  A.M. Funds Roundup: What Follows Dow 20,000? Investors Leave Vanguard Growth ETF at Barrons.com
07:41AM  Thursday Hot Reads: Dow 20K Yellow Flag For Some Investors ETF.com
Jan-25-17 10:36AM  Celgene to File NDA for Ozanimod as Multiple Sclerosis Therapy Market Realist
10:36AM  Celgene to File NDA for Ozanimod as Multiple Sclerosis Therapy
10:04AM  Smart-Beta ETFs for 2017 (USMV, VUG) at Investopedia
Jan-19-17 08:44AM  These Growth ETFs Are Popular With Investors
08:27AM  Growth ETF (VUG) Hits New 52-Week High
Jan-16-17 09:06AM  Intuitive Surgical and the Performance of Its Stock
Jan-11-17 11:05AM  5 Growth ETFs & Stocks Set for Explosive Gains in 2017
Jan-09-17 11:51AM  Large-Cap Growth ETFs Warming Up This Winter
Jan-03-17 07:36AM  BDs Medical Segment Performance and Growth Strategy
Dec-22-16 10:37AM  Bristol-Myers Squibbs Opdivo May See Strong Demand in 2016
Dec-19-16 10:35AM  Understanding the Key Drivers of EWs Critical Care Business Growth
Dec-07-16 08:12AM  Vanguards Rampulla On The New Active Mgmt
Dec-02-16 10:04AM  Acute Myeloid Leukemia: Growth Opportuny for AbbVies Venclexta?
Dec-01-16 10:05AM  Nevro Lawsuit against BSX Could Impact Its Neuromodulation Revenues
The investment seeks to track the performance of a benchmark index that measures the investment return of large-capitalization growth stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Growth Index, a broadly diversified index predominantly made up of growth stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.